2108.4000 66.00 (3.23%)
NSE Sep 18, 2025 15:31 PM
Volume: 1.1M
 

2108.40
3.23%
IDBI Capital
Glenmarks's Q1FY19 results were a mixed bag, while the sales and EBITDA were 9.9%/ 10.9% below our expectations; APAT was up 7.8% over IDBIEst. given higher Other Income which included Rs125Cr of forex gain. Sales were down 8.4% YoY (-5% QoQ) at...
Glenmark Pharmaceuticals Ltd. has gained 47.48% in the last 6 Months
More from Glenmark Pharmaceuticals Ltd.
Recommended